ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Quotient Bioresearch, a Cambridge, England-based drug development services firm, has opened a radiochemistry facility in Cardiff, England. The opening follows the company’s acquisition of Amersham Radiolabeling Services from GE Healthcare in June 2009.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter